Basic stats
EPIC "RSW" "EPIC" NAME "RENISHAW" "Company name" SECT "ELECTRONIC AND ELECTRICAL EQUI" "Sector" INDEX "FTSE250" "INDEX" PER0 15.9 "Curr PER" PE20 15.75 "PER10 P20" PE50 18.1 "PER10 P50" PE80 24.75 "PER10 P80" RREV 1.59 "REL CHANGE IN REVENUE" OPMM 16.4 "OPM median" YLD 2.71 "Yield (%)" Z 7.98 "Z Score" MKT 979.0 "MKT CAP (£m)" ROE0 31.9 "Current ROE" ROE10 15.5 "ROE median" SP 1344.5 "Share Price (p)" GRATE 18.92 "Graham EPS growth rate%" XRATE 10.99 "Exp-fit EPS growth rate%" SREPS 0.35 "Spearman rank of EPSa" UPD "Last Updated: Fri 23 Mar 2012" "Updated on Sharelock"
Google finance decription:
Renishaw plc is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products. The Company operates in two segments: metrology and healthcare products. Products available include laser tool setters, contact tool setters, tool breakage detectors, touch probes and high accuracy inspection probes. It offers medical devices, surgical robots and planning software for use in stereotactic neurosurgery for procedures. During the fiscal year ended June 30, 2011 (fiscal 2011), it acquired a 49% interest in Measurement Devices Limited (MDL), and acquired the remaining minority shareholding in PulseTeq Limited, increasing its shareholding to 100%. On April 8, 2011, it acquired a 100% interest in MTT Investments Limited (MTT). On June 16, 2011, the Company acquired a 100% interest in Aberlink Limited.
"Metrology" is "the science of measurement. So, measurement equipment.
"Spectroscopy" is "the study of the interaction between matter and radiated energy". Radiative energy can take the form of electromagnetic, particles (e.g. electrons and neutrons), acoustic, or mechanical.
Stereotactic is "a minimally invasive form of surgical intervention which makes use of a three-dimensional coordinate system to locate small targets inside the body and to perform on them some action such as ablation, biopsy, lesion, injection, stimulation, implantation, radiosurgery (SRS) etc."
Half-yearly report issued on 25-Jan-2012:
Revenue up 11%. Increased R&D ro support growth. Growth in marketing and distribution infrastructure. Further investment in manufacturing capacity. Established a new subsidiary in Mexico. The outlook for continuing global investment for production systems in automotive, civil aviation, agriculture and energy (including oil, gas and renewables) looks increasingly favourable.
=-=-=-=-=
Powered by Blogilo
Mark Carter's blog 